Masatake Kobayashi

19PUBLICATIONS
50CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Major global burdens of diseaseRespiratory diseasesRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 27, 2026
Redefining Cardiometabolic Disease: Expert Consensus on the CardioVascular-Kidney-Liver-Metabolic (CVKLM) Multiorgan Staging.

|Oct 06, 2026
Kidney function decline, heart failure hospitalization, and the effect of empagliflozin in heart failure: an EMPEROR-pooled analysis.

|Aug 03, 2026
Mineralocorticoid receptor overactivation in heart failure with preserved ejection fraction.

|May 06, 2026
Worsening Renal Function at 1 Year After Acute Heart Failure: A Report From the WET-HF2 Registry.

|Feb 19, 2026
Real-world data on early initiation of sodium-glucose co-transporter-2 inhibitors in newly diagnosed heart failure with reduced ejection fraction.

Masatake Kobayashi, Luca Monzo, Guillaume Baudry

|Jul 30, 2025
Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction.

Masatake Kobayashi, Antoni Bayes-Genis, Kevin Duarte

Pageof 4

Frequent Collaborators

5 joint publications

Nicolas Girerd

4 joint publications

Faiez Zannad

3 joint publications

Bertram Pitt

2 joint publications

Javed Butler